Prospective phase II clinical study aim to explore the clinical outcome of patients with unresectable locally recurrent rectal cancer (LRRC) treated with re-irradiation by carbon ion radiotherapy (CIRT)
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
31
patients with unresectable local recurrent rectal cancer will be treated with carbon ion radiation therapy as re-irradiation
Shanghai Proton and Heavy ion center
Shanghai, Pudong, China
local control
local control rate of the lesion treated by CIRT
Time frame: Local control at 3 years after CIRT
overall survival
survival rate after CIRT
Time frame: 3 years after CIRT or patient died, measured erery 3 months after CIRT
progression free survival
progression free survival rate after CIRT
Time frame: 3 years after CIRT or patient died, measured erery 3 months after CIRT
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.